Atherosclerotic peripheral vascular disease symposium II lower-extremity revascularization: State of the art

Circulation

Volumn 118, Issue 25, 2008, Pages 2864-2872

  Gray, Bruce H ^a   Conte, Michael S ^a   Dake, Michael D ^a   Jaff, Michael R ^a   Kandarpa, Krishna ^a   Ramee, Stephen R ^a   Rundback, John ^a   Waksman, Ronald ^a  

^a NONE

Author keywords

AHA conference proceedings; Arteriosclerosis; Claudication; Peripheral vascular disease; Revascularization

Indexed keywords

ABCIXIMAB; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ALGORITHM; ATHEROSCLEROSIS; BLEEDING; BLOOD CLOT LYSIS; CATHETER; CONFERENCE PAPER; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; GUIDE WIRE; HUMAN; LEG REVASCULARIZATION; LIMB ISCHEMIA; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RESTENOSIS; SURGICAL THROMBECTOMY;

AMERICAN HEART ASSOCIATION; ANIMALS; ATHEROSCLEROSIS; HUMANS; LOWER EXTREMITY; PERIPHERAL VASCULAR DISEASES; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 58249135897     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.191177     Document Type: Conference Paper

References (23)

1. TASC Working Group. Management of peripheral arterial disease: TransAtlantic Inter-Society Consensus (section C). J Vasc Surg. 2000;31:S135-S167.
2. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version [published correction appears in J Vasc Surg. 2001;33:805].
3. J Vasc Surg. 1997;26:517-538.
4. The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE trial. Ann Surg. 1994;220:251-266.
5. Kasirajan K, Gray B, Beavers FP, Clair DG, Greenberg R, Mascha E, Ouriel K. Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Rad. 2001;12:413-421.
6. Ouriel K, Shorten CK, De Weese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19:1021-1030.
7. Ouriel K, Veith FJ, Sasahara AA; Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. A comparison of recombinant urokinase with vascular surgery as an initial treatment for acute arterial occlusions of the leg. N Engl J Med. 1998;338:1105-1111.
8. Hirsch AT, Haskai ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Andersen JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Medicine and Biology. Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006;47:1-192.
9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR. Harris KA, Fowkes FG; TASC II Working Group, Bell K. Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E III, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:(suppl):S1-S75.
10. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H; BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934.
11. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Bercili SA, DeMasi RJ, Samson RH, Bermann SS; PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742-751.
12. Laird JR, Zeller T, Gray BH, Scheinen D, Vranic M, Reiser C, Biamino G; LACI Investigators. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13:1-11.
13. Melzi G, Cosgrove J, Biondi-Zoccai GL, Airoldi F, Michev I, Chieffo A, Sangiorgi GM, Montorfano M, Carlino M, Colombo A. A novel approach to chronic total occlusions: the Grosser system. Catheter Cardiovasc Interv. 2006;68:29-35.
14. Zeller T, Rastan A. Sixt S, Schwarzwälder U, Schwarz T, Frank U. Bürgelin K, Müller C, Rothenpieler U, Flügel PC, Tepe G, Neumann FJ. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. 2006;48:1573-1578.
15. Mahmud E, Keramati S, Salami A, Palakodeti V, Tsimikas S. Expanded applications of rotational athereclomy in contemporary coronary and peripheral interventional practice. J Invasive Cardiol. 2005;17:207-210.
16. Zhou W, Bush RL, Lin PH, Peden EK, Lumsden AB. Laser atherectomy for lower extremity revascularization: an adjunctive endovascular treatment option. Vasc Endovascular Surg. 2006;40:268-274.
17. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Bérégi JP. Sirolimus-eluting stems for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505-1509.
18. Duda SH, Bosiers M, Lammer J, Scheinen D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Bérégi JP. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338.
19. Ubbink DT, Fidler M, Legemate DA. Interobserver variability in aortoiliac and femoropopliteal duplex scanning. J Vasc Surg. 2001;33:540-545.
20. Pokrajac B, Schmid R, Kirisits C, Mock U, Fellner C, Wambersie A, Potter R, Minar E, Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Radiother Oncol. 2002;63:97-102.
21. Peelers P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stems in palients with critical limb ischemia. J Endovasc Ther. 2005;12:1-5.
22. Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol. 2004;94:1174-1177.
23. Michalis LK, Rees MR, Patsouras D, Katsouras CS, Goudevenos J, Pappas S, Sourla E, Kolettis T, Sioros L, Zotou P, Gartzou-Matsouka P, Sideris DA. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal. Vasoseal and Duett). Cardiovasc Intervent Radiol. 2002;25:423-429.